hiPSC from Doetinchem Cohort Study round 8 2024-2028

hiPSC from Doetinchem Cohort Study round 8 2024-2028 - hiPSC from Doetinchem Cohort Study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON57454

Enrollment

Registered

2025-04-28

Start date

2025-09-10

Completion date

Unknown

Last updated

2025-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gezondheid en ziekten t.b.v. de volksgezondheid health and disease

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Belonging to the subset of 5000 genotyped Doetinchem Cohort Study participants. - Already participated in the ongoing measurement round 8 of the Doetinchem Cohort Study.

Exclusion criteria

Exclusion criteria: - Cancer patients (past or present); - Individuals knowingly having an HIV or Hepatitis C infection.

Design outcomes

Primary

Measure	Time frame
- Ability to generate hiPSCs and differentiated derivative cells from healthy somatic cells - Ability to generate mutated cell lines using gene-editing - Ability to study disease phenotype in mutated cell lines and compare it to the control iso-genic cell lines	—

Secondary

Measure	Time frame
n.a.	—

Countries

Netherlands

Outcome results